5876-97-1 Usage
Molecular Weight
267.21 g/mol
Structure
A derivative of resorcinol with a nitro group at the 3rd position and a benzoate group at the 1st position
Appearance
Yellow crystalline solid
Solubility
Soluble in organic solvents like ethanol, acetone, and diethyl ether
Melting Point
198-202°C
Boiling Point
Not readily available, but expected to be high due to the presence of multiple functional groups
Density
Not readily available, but expected to be higher than water due to the presence of aromatic rings and functional groups
Polarity
Polar due to the presence of hydroxyl and nitro groups
Uses
a. Manufacturing of dyes
b. Production of pharmaceuticals
c. Intermediate in organic synthesis
d. Antioxidant properties in the cosmetic industry
Hazards
a. Harmful if ingested
b. Harmful if inhaled
c. Harmful if it comes into contact with the skin
d. Potential respiratory and skin sensitizer
Safety Precautions
Handle with care, use personal protective equipment (gloves, goggles, mask), and store in a well-ventilated area away from heat and ignition sources
Environmental Impact
Potentially harmful to aquatic life and should be disposed of according to local regulations
Regulatory Status
May be subject to specific regulations depending on the country or region, such as the European Union's REACH regulation or the US EPA's Toxic Substances Control Act (TSCA)
Check Digit Verification of cas no
The CAS Registry Mumber 5876-97-1 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 5,8,7 and 6 respectively; the second part has 2 digits, 9 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 5876-97:
(6*5)+(5*8)+(4*7)+(3*6)+(2*9)+(1*7)=141
141 % 10 = 1
So 5876-97-1 is a valid CAS Registry Number.
5876-97-1Relevant academic research and scientific papers
CONDENSED RING COMPOUND AND USE THEREOF
-
Page/Page column 95, (2010/11/08)
The present invention relates to a compound of formula (I) (wherein all symbols have the same meanings as described hereinbefore). The compound antagonizes cysLT2 and therefore, it is useful as an agent for the prevention and/or treatment of respiratory diseases such as bronchial asthma, bronchial asthma, chronic obstructive pulmonary disease, pneumonectasia, chronic bronchitis, pneumonia (e.g. interstitial pneumonitis etc.), severe acute respiratory syndrome (SARS), acute respiratory distress syndrome (ARDS), allergic rhinitis, sinusitis (e.g. acute sinusitis, chronic sinusitis, etc.), and the like, or as an expectorant or antitussives.
